Literature DB >> 17387569

Is stapled hemorrhoidopexy safe for the male homosexual patient? Report of a case.

Tihomir Kekez1, Kresimir Bulic, Dubravko Smudj, Mate Majerovic.   

Abstract

Stapled hemorrhoidopexy is becoming a widely accepted surgical treatment for third- and fourth-degree hemorrhoids because it is associated with much less postoperative pain than open hemorrhoidectomy. After the procedure, a circular line of staples is left in the anal canal; therefore, there is a risk of penile injury or condom damage during anal intercourse, which increases the risk of exposure to sexually transmitted diseases. We report the case of a male homosexual patient who engaged in anal intercourse after recovering from a stapled hemorrhoidopexy, resulting in condom damage. We did not consider this possibility and neglected to discuss the issue with the patient. With an estimated 2.5% of the general population being exclusive, male homosexuals, it is necessary to inform such patients to refrain from anal intercourse after hemorrhoidopexy, although there are no reports stating how long this restraint should last.

Entities:  

Mesh:

Year:  2007        PMID: 17387569     DOI: 10.1007/s00595-006-3378-3

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  7 in total

Review 1.  Demographics of the gay and lesbian population in the United States: evidence from available systematic data sources.

Authors:  D Black; G Gates; S Sanders; L Taylor
Journal:  Demography       Date:  2000-05

Review 2.  Stapled haemorrhoidopexy: a consensus position paper by an international working party - indications, contra-indications and technique.

Authors:  M L Corman; J-F Gravié; T Hager; M A Loudon; D Mascagni; P-O Nyström; F Seow-Choen; H Abcarian; P Marcello; E Weiss; A Longo
Journal:  Colorectal Dis       Date:  2003-07       Impact factor: 3.788

Review 3.  American Gastroenterological Association technical review on the diagnosis and treatment of hemorrhoids.

Authors:  Robert D Madoff; James W Fleshman
Journal:  Gastroenterology       Date:  2004-05       Impact factor: 22.682

4.  Long-term results after excision haemorrhoidectomy versus stapled haemorrhoidopexy for prolapsing haemorrhoids; a Belgian prospective randomized trial.

Authors:  J Van de Stadt; A D'Hoore; M Duinslaeger; E Chasse; F Penninckx
Journal:  Acta Chir Belg       Date:  2005-02       Impact factor: 1.090

5.  Symptomatic hemorrhoids: current incidence and complications of operative therapy.

Authors:  R Bleday; J P Pena; D A Rothenberger; S M Goldberg; J G Buls
Journal:  Dis Colon Rectum       Date:  1992-05       Impact factor: 4.585

6.  Stapled hemorrhoidopexy versus milligan-morgan hemorrhoidectomy: a prospective, randomized, multicenter trial with 2-year postoperative follow up.

Authors:  Jean François Gravié; Paul-Antoine Lehur; Noël Huten; Marc Papillon; Michel Fantoli; Bernard Descottes; Patrick Pessaux; Jean-Pierre Arnaud
Journal:  Ann Surg       Date:  2005-07       Impact factor: 12.969

7.  A prospective, randomized, controlled multicenter trial comparing stapled hemorrhoidopexy and Ferguson hemorrhoidectomy: perioperative and one-year results.

Authors:  A J Senagore; M Singer; H Abcarian; J Fleshman; M Corman; S Wexner; S Nivatvongs
Journal:  Dis Colon Rectum       Date:  2004-11       Impact factor: 4.585

  7 in total
  3 in total

Review 1.  Documented complications of staple hemorrhoidopexy: a systematic review.

Authors:  Liesel J Porrett; Jemma K Porrett; Yik-Hong Ho
Journal:  Int Surg       Date:  2015-01

Review 2.  Agraffectomy after low rectal stapling procedures for hemorrhoids and rectocele.

Authors:  S Petersen; J Jongen; W Schwenk
Journal:  Tech Coloproctol       Date:  2011-06-22       Impact factor: 3.781

Review 3.  Postoperative complications after procedure for prolapsed hemorrhoids (PPH) and stapled transanal rectal resection (STARR) procedures.

Authors:  M Pescatori; G Gagliardi
Journal:  Tech Coloproctol       Date:  2008-05-30       Impact factor: 3.781

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.